Can tigecycline's metabolism explain its every 12 hour dosing?

Short answer: Not primarily. Tigecycline’s dosing every 12 hours isn’t driven by its metabolism.

Key points:
- Metabolism: Tigecycline is not significantly metabolized by the liver. It is eliminated mostly as unchanged drug, mainly via biliary/fecal excretion. There is little renal excretion and only minor hepatic metabolism.
- PK/PD driver: The dosing interval is driven by pharmacokinetics/pharmacodynamics (PK/PD) targets, especially the AUC/MIC relationship for a bacteriostatic antibiotic. The goal is to achieve and maintain sufficient overall exposure (AUC) relative to the pathogen’s MIC, not to compensate for metabolic rate.
- Why 12-hour dosing: Tigecycline has a very large volume of distribution and a long elimination half-life. The standard regimen uses a 100 mg loading dose followed by 50 mg every 12 hours to rapidly achieve tissue exposure and then maintain adequate exposure over time (steady-state AUC). Because plasma concentrations can be low while tissue concentrations remain high, the schedule helps sustain the therapeutic effect.
- Practical notes:
- It’s not primarily about how fast the liver processes the drug.
- In many patients, no dose adjustment for renal impairment is needed; data for severe hepatic impairment are limited, so clinicians may use clinical judgment and guidelines.
- Tigecycline’s PK/PD characteristics also influence its use in certain infections (e.g., bacteremia) where tissue penetration and very low plasma levels may not be ideal.

If you’d like, I can pull specific PK values (half-life, volume of distribution, AUC targets) or explain how the AUC/MIC target translates into the recommended dosing for particular pathogens.